Artemis Medicare Services Ltd. (ARTEMISMED) AI Stock Analysis

• Market Cap: ₹40.87B
• Dividend Yield: 0.16%
• Average Volume (3M): 16.54K
• Price to Earnings (P/E): 37.6
• Beta (1Y): 1.26
• Revenue Growth: 10.27%
• EPS Growth: 45.15%
• Country: IN
• Employees: 1,991
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 2.20
• Shares Outstanding: 158,273,650
• 10 Day Avg. Volume: 28,644
• 30 Day Avg. Volume: 16,535
• PEG Ratio: 1.06
• Price to Book (P/B): 5.05
• Price to Sales (P/S): 4.51
• P/FCF Ratio: 80.55
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 74 Outperform
• Price Target: ₹302.00 ▲(9.34% Upside)

Artemis Medicare Services Ltd. has a strong financial foundation with robust revenue growth and profitability improvements. The technical analysis suggests bullish momentum, though caution is advised due to potential overbought conditions. Valuation metrics indicate the stock may be overvalued, which could limit upside potential. Overall, the stock is well-positioned in its industry but may face valuation challenges.

Positive Factors

Revenue Growth

Strong revenue growth over five years indicates a robust expansion trajectory, suggesting the company is effectively capturing market opportunities.

Profitability Improvements

Improved profit margins reflect effective cost management, enhancing the company's profitability and competitive positioning in the healthcare sector.

Cash Flow Generation

Strong cash flow growth supports liquidity and financial flexibility, enabling reinvestment in growth initiatives and debt reduction.

Negative Factors

EBITDA Margin

Lower EBITDA margins compared to industry leaders may limit profitability potential, necessitating focus on operational efficiencies.

Free Cash Flow Conversion

Improving free cash flow conversion is crucial for sustaining long-term investments and financial health, requiring better capital management.

Net Debt Fluctuations

Fluctuating net debt levels can impact financial stability, necessitating careful management to avoid potential liquidity issues.

Artemis Medicare Services Ltd. Business Overview & Revenue Model

Company Description

Artemis Medicare Services Limited manages and operates multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a 541 bed multi-specialty hospital located in Gurugram, India. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.

How the Company Makes Money

ARTEMISMED generates revenue through multiple streams, primarily by billing patients and insurance providers for medical services rendered in its facilities, including surgeries, consultations, and diagnostic tests. Additionally, the company earns income from telemedicine services, allowing patients to access healthcare remotely. Key partnerships with health insurance companies help streamline reimbursements and expand service offerings to a broader patient base. Furthermore, ARTEMISMED may participate in government healthcare programs and initiatives, which can provide additional funding and revenue opportunities. The strategic focus on quality care and technological integration also attracts investment and grants, contributing positively to the overall financial performance.

Artemis Medicare Services Ltd. Financial Statement Overview

Summary

Artemis Medicare Services Ltd. shows strong financial performance with consistent revenue growth, improved profitability margins, and stable financial leverage. The company has effectively managed costs and capital allocation, although there is room for improvement in EBITDA margins and free cash flow conversion.

Income Statement

Artemis Medicare Services Ltd. has demonstrated consistent revenue growth with a 68% increase over the past five years, indicating a strong expansion trajectory. The gross profit margin improved significantly, reaching 24% in the latest year, reflecting effective cost management. The net profit margin also showed a robust upward trend, growing to 9% from 1% in 2021. This indicates enhanced profitability through operational efficiencies. However, there is room for improvement in EBITDA margins, which remain below industry leaders.

Balance Sheet

The company's balance sheet is solid, with a healthy equity ratio of 62% indicating strong financial stability. The debt-to-equity ratio has decreased over the years to 0.35, showcasing effective debt management and reduced leverage risk. Return on equity also improved to nearly 10%, reflecting better utilization of shareholder funds. However, the company experienced fluctuations in net debt, which could pose risks if not managed carefully.

Cash Flow

Artemis Medicare's cash flow statements reveal a positive trend in free cash flow, growing by 44% compared to the previous year. The operating cash flow to net income ratio is strong at 1.76, indicating efficient cash generation from operations. The free cash flow to net income ratio is slightly lower but still healthy at 0.63. These metrics suggest good liquidity and effective capital expenditure management, although further improvement in free cash flow conversion would be beneficial.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	9.69B	9.37B	8.79B	7.37B	5.53B	4.08B
Gross Profit	2.29B	2.23B	1.78B	1.04B	954.40M	371.67M
EBITDA	1.50B	1.52B	1.25B	1.01B	713.53M	359.53M
Net Income	872.38M	826.26M	491.41M	385.98M	318.14M	64.86M
Balance Sheet
Total Assets	0.00	13.57B	9.72B	9.05B	7.10B	6.00B
Cash, Cash Equivalents and Short-Term Investments	3.95B	3.96B	612.05M	509.42M	276.98M	311.20M
Total Debt	0.00	2.90B	3.20B	2.86B	2.01B	1.47B
Total Liabilities	-8.44B	5.14B	5.17B	4.97B	3.48B	2.78B
Stockholders Equity	8.44B	8.38B	4.48B	4.03B	3.59B	3.20B
Cash Flow
Free Cash Flow	0.00	524.65M	363.01M	-337.68M	-573.20M	-162.62M
Operating Cash Flow	0.00	1.46B	1.09B	1.13B	515.80M	182.39M
Investing Cash Flow	0.00	-3.85B	-891.04M	-1.58B	-1.08B	-378.47M
Financing Cash Flow	0.00	2.67B	-41.48M	521.82M	528.37M	271.62M

Artemis Medicare Services Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 276.20
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ARTEMISMED, the sentiment is Negative. The current price of 276.2 is above the 20-day moving average (MA) of 273.67, above the 50-day MA of 270.84, and above the 200-day MA of 255.41, indicating a neutral trend. The MACD of -1.64 indicates Positive momentum. The RSI at 36.71 is Neutral, neither overbought nor oversold. The STOCH value of 22.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ARTEMISMED.

Artemis Medicare Services Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ARTEMISMED	74 Outperform	₹40.87B	37.62	―	0.16%	10.27%	45.15%
INDRAMEDCO	69 Neutral	₹37.83B	21.65	―	0.96%	6.51%	18.24%
KIMS	65 Neutral	₹248.11B	73.11	―	―	25.74%	1.41%
FORTIS	61 Neutral	₹681.12B	67.17	―	0.11%	15.33%	54.62%
METROPOLIS	61 Neutral	₹99.74B	62.88	―	0.21%	15.41%	5.93%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SHALBY	49 Neutral	₹19.75B	435.67	―	0.59%	11.49%	-91.65%

Artemis Medicare Services Ltd. Corporate Events

Artemis Medicare Services Expands Equity Through Stock Option Plan

Artemis Medicare Services Ltd. has announced the allotment of 105,750 equity shares as part of its Artemis Medicare Management Stock Option Plan-2021, approved by the Nomination and Remuneration Committee. This move results in an increase in the company’s issued and paid-up equity share capital, underlining its commitment to employee incentivization and its operational growth strategy.

Artemis Medicare Services Releases Q2 & H1 FY26 Earnings Call Transcript

Artemis Medicare Services Ltd. released the transcript of its Q2 and H1 FY26 earnings conference call, highlighting the company’s operational and financial performance. The release provides insights into the company’s current market positioning and strategic initiatives, which are crucial for stakeholders to understand the company’s growth trajectory and financial health.